Large Granular Lymphocyte Leukemia - 27 Studies Found
Completed |
: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma :
: |
Active, not recruiting |
: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies :
: |
Withdrawn |
: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies :
|
Active, not recruiting |
: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant :
|
Active, not recruiting |
: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma :
|
RECRUITING |
: Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia : T-Cell Large Granular Lymphocyte Leukemia : 2024-05-12 : Given PO |
RECRUITING |
: Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) : Large Granular Lymphocyte Leukemia : 2024-05-12 : Siltuximab will be given on day 1 of each cycle.The dose will be 11 mg/kg given over 1 hour by intravenous infusion.Each cycle is thr |